Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Stell

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Oncogene|December 1, 1989
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinomaJ K Field, D A Spandidos, P M Stell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinomaJ K Field, M Yiagnisis, D A Spandidos, et al.
British Journal of Clinical Pharmacology|January 1, 1992
Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neckJ D Holding, W E Lindup, C van Laer, et al.
The Journal of Laryngology and Otology|August 1, 1990
Alternating cisplatinum and VAC ineffective in end stage squamous cell carcinoma of the head and neckM Z Siodlak, P M Stell, J A Wilson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trialR P Morton, F Rugman, E B Dorman, et al.
Sonderbande Zur Strahlentherapie Und Onkologie|January 1, 1987
[Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study]R P Morton, F Rugman, E B Dorman, et al.
Clinical Otolaryngology and Allied Sciences|February 1, 1989
Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term resultsM Z Siodlak, J E Dalby, P J Bradley, et al.
Clinical Otolaryngology and Allied Sciences|June 1, 1987
Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinumJ B Campbell, E B Dorman, T R Helliwell, et al.
Acta Oto-Laryngologica|May 1, 1987
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancerJ B Campbell, E B Dorman, M McCormick, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Oncogene|December 1, 1989
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinomaJ K Field, D A Spandidos, P M Stell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinomaJ K Field, M Yiagnisis, D A Spandidos, et al.
British Journal of Clinical Pharmacology|January 1, 1992
Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neckJ D Holding, W E Lindup, C van Laer, et al.
The Journal of Laryngology and Otology|August 1, 1990
Alternating cisplatinum and VAC ineffective in end stage squamous cell carcinoma of the head and neckM Z Siodlak, P M Stell, J A Wilson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trialR P Morton, F Rugman, E B Dorman, et al.
Sonderbande Zur Strahlentherapie Und Onkologie|January 1, 1987
[Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study]R P Morton, F Rugman, E B Dorman, et al.
Clinical Otolaryngology and Allied Sciences|February 1, 1989
Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term resultsM Z Siodlak, J E Dalby, P J Bradley, et al.
Clinical Otolaryngology and Allied Sciences|June 1, 1987
Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinumJ B Campbell, E B Dorman, T R Helliwell, et al.
Acta Oto-Laryngologica|May 1, 1987
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancerJ B Campbell, E B Dorman, M McCormick, et al.
Pageof 20